Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Rheumatoid Arthritis: HELP
Dr. Mark Genovese
Based on 84 articles published since 2007
||||
Expertise Level
The expertise of Dr. Mark Genovese ranks in the
  • Top 0.031%
  • ... of 80,178 published authors worldwide on Rheumatoid Arthritis
  • ... from 2007 through 2018
  • ... based on contributions to 84 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Genovese, M   ·   Genovese, Mark   ·   Genovese, M C   ·   Genovese, Mark C
Work Locations
Details
Confirmed:
(June 2014) 
  Stanford University   Contact    
2017
  • Department of Musculoskeletal Biology, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK. · Department of Rheumatology, University of South Florida, Tampa, FL. · Medicine/Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Department of Rheumatology, Addenbrookes Hospital, Cambridge. · Roche Products Limited, Welwyn Garden City, UK. · Department of Internal Medicine, University of Cologne, Cologne, Germany. · Department of Medicine, Karolinska Institute, Stockholm, Sweden. · Division of Rheumatology, Stanford University Medical Center, Palo Alto, CA, USA. · Pubmed 28013198
  • Metroplex Clinical Research Center, Dallas, Texas, USA. · Stanford University School of Medicine, Palo Alto, California, USA. · CREATE Centre, Section of Rheumatology, Institute of Infection and Immunity, Cardiff University, Cardiff, UK. · Rheumatology Division, Cruces University Hospital, OSI EE-Cruces and Biocruces Health Research Institute, Vizcaya, Spain. · Arthritis and Rheumatism Associates, Wheaton, Maryland, USA. · Na Slupi 4 Praha 2, Praha, Czech Republic. · Instituto de Investigación Hospital 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain. · Advanced Arthritis Care & Research, Scottsdale, Arizona, USA. · Department of Rheumatology and Clinical Immunology, Poznań University of Medical Sciences, Poznań, Poland. · Amgen Inc., Thousand Oaks, California, USA. · RANA Clinical Research Center, Huntsville, Alabama, USA. · Pubmed 28584187
  • Stanford University, Palo Alto, California. · Desert Medical Advances, Palm Desert, California. · Health Research of Oklahoma, Oklahoma City. · ARS Rheumatica, Warsaw, Poland. · Altoona Center for Clinical Research, Duncansville, Pennsylvania. · Astellas Pharma Global Development, Northbrook, Illinois. · Centro de Investigación Clínica de Morelia SC, Morelia, Mexico. · Pubmed 28118538
  • Albany Medical College, Albany, New York. · Stanford University Medical Center, Palo Alto, California. · University of Toronto, Toronto, Ontario, Canada. · University of Oxford, Oxford, UK. · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 28029752
  • Medical University of Vienna and Hietzing Hospital, Vienna, Austria. · Albany Medical College, Albany, New York, USA. · Eli Lilly and Company, Indianapolis, Indiana, USA. · University of New South Wales, Sydney, New South Wales, Australia. · Divisions of Rheumatology, Ophthalmology and Immunology, Valme University Hospital, Sevilla, Spain. · Stanford University Medical Center, Palo Alto, California, USA. · Lapeyronie Hospital, Montpellier University, Montpellier, France. · Pubmed 27799159
  • Altoona Center for Clinical Research, Duncansville, Pennsylvania. · Hospital Civil de Guadalajara, Guadalajara, Mexico. · Arthritis Associates, Orlando, Florida. · Stanford University, Palo Alto, California. · Astellas Pharma Global Development, Northbrook, Illinois. · ARS Rheumatica, Warsaw, Poland. · Pubmed 27748083
  • Stanford University Medical Center, Palo Alto, California. · Albany Medical College, Albany, New York. · Karolinska Institute, Stockholm, Sweden (current address: Amsterdam Rheumatology and Immunology Center, Academic Medical Center, Amsterdam, The Netherlands). · University of Berlin, Berlin, Germany. · Durand University Hospital, Buenos Aires, Argentina. · Genentech, Inc., South San Francisco, California. · Roche Products Ltd., Welwyn Garden City, UK. · Pubmed 28597609
  • Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Free University and Humboldt University of Berlin, Berlin, Germany. · Cardiff University, Cardiff, UK. · Altoona Center for Clinical Research, Duncansville, Pennsylvania, USA. · Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Osaka, Japan. · Division of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, Osaka, Japan. · Genentech, Inc., South San Francisco, California, USA. · Chugai Pharmaceutical Co., Ltd., Tokyo, Japan. · Roche Products Limited, Welwyn Garden City, UK. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · Roche Innovation Center, New York, New York, USA. · Roche Pharma Research and Early Development, Roche Innovation Center, Basel, Switzerland. · Roche Pharma Research and Early Development, Roche Innovation Center, Munich, Germany. · Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, California, USA. · Pubmed 28007755
  • Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Free University and Humboldt University of Berlin, Berlin, Germany. · Clinical Immunology and Rheumatology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. · Division of Immunology and Rheumatology, Stanford University, Palo Alto, California, USA. · Immunology Clinical Development, AbbVie, North Chicago, Illinois, USA. · Clinical Pharmacology and Pharmacometrics, AbbVie, North Chicago, Illinois, USA. · Data and Statistical Sciences, AbbVie, North Chicago, Illinois, USA. · Pubmed 27338778
2016
  • Stanford University Medical Center, Palo Alto, CA, USA. · Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, 94303, USA. · , Mailing address: 306 Ramona Road, Portola Valley, California, 94028, USA. · Optum, Lincoln, RI, USA. · Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA. · Sanofi Genzyme, Bridgewater, NJ, USA. · now with Novartis, East Hanover, NJ, USA. · Leiden University Medical Centre, Leiden, The Netherlands. · Stanford University Medical Center, Palo Alto, CA, USA. · Pubmed 27600829
  • Stanford University School of Medicine, Palo Alto, California. · Medical University of Vienna and Hietzing Hospital, Vienna, Austria. · Brigham and Women's Hospital, Boston, Massachusetts. · Charité-Universitätsmedizin Berlin, Berlin, Germany. · AbbVie Deutschland, Ludwigshafen, Germany. · AbbVie, North Chicago, Illinois. · Pubmed 27390150
  • Division of Rheumatology, Stanford University, Palo Alto, CA, USA. · Unit for Clinical Therapy Research, Inflammatory Diseases, Karolinska Institute, Stockholm, Sweden. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, 500 Arcola Drive, F5352, Collegeville, PA, 19426, USA. · Pfizer Inc, 500 Arcola Drive, F5352, Collegeville, PA, 19426, USA. · Pubmed 27334658
  • Schlosspark-Klinik University Medicine, Berlin, Germany. · University Medicine Berlin, Berlin, 14059, Germany. · Johns Hopkins University, Baltimore, MD, USA. · Metroplex Clinical Research Center, Dallas, TX, USA. · University of Alabama at Birmingham, Birmingham, AL, USA. · Bristol-Myers Squibb, Princeton, NJ, USA. · Stanford University, Palo Alto, CA, USA. · Pubmed 27229685
  • Division of Immunology and Rheumatology, Stanford University, Palo Alto, California, USA. · Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA. · Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet-Glostrup, University of Copenhagen, Copenhagen, Denmark. · Pubmed 27084959
  • From the Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, California; Eli Lilly and Company, Indianapolis, Indiana; Bristol-Myers Squibb, Princeton, New Jersey, USA.M.C. Genovese, MD, James W. Raitt Professor of Medicine, Co-Chief of Division of Immunology and Rheumatology, Stanford University School of Medicine; D.K. Braun, MD, Medical Fellow; Eli Lilly and Company; J.S. Erickson, PhD, Statistician, Eli Lilly and Company; P.Y. Berclaz, MD, Senior Medical Director, Eli Lilly and Company; M.P. Heffernan, MD, Senior Medical Director, Eli Lilly and Company; H. Carlier, MD, Senior Medical Advisor, Eli Lilly and Company, Indianapolis; S. Banerjee, MD, Bristol-Myers Squibb. · From the Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, California; Eli Lilly and Company, Indianapolis, Indiana; Bristol-Myers Squibb, Princeton, New Jersey, USA.M.C. Genovese, MD, James W. Raitt Professor of Medicine, Co-Chief of Division of Immunology and Rheumatology, Stanford University School of Medicine; D.K. Braun, MD, Medical Fellow; Eli Lilly and Company; J.S. Erickson, PhD, Statistician, Eli Lilly and Company; P.Y. Berclaz, MD, Senior Medical Director, Eli Lilly and Company; M.P. Heffernan, MD, Senior Medical Director, Eli Lilly and Company; H. Carlier, MD, Senior Medical Advisor, Eli Lilly and Company, Indianapolis; S. Banerjee, MD, Bristol-Myers Squibb. · Pubmed 26669919
  • Stanford University, Palo Alto, California. · Karolinska Institute, Stockholm, Sweden. · Universidad Autónoma de Chihuahua, Chihuahua, Mexico. · Vertex Pharmaceuticals Incorporated, Boston, Massachusetts. · Pubmed 26473751
  • Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany. · Service et Pôle de Rhumatologie, Cliniques Universitaires Saint-Luc, and Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Rheumatology, Brussels, Belgium. · Department of Internal Medicine, City Clinical Hospital, Nizhny Novgorod, Russia. · Division of Rheumatology and Clinical Immunology, Stanford University, Stanford, CA, USA. · Division of Rheumatology and Clinical Immunology, Medizinische Klinik and Poliklinik IV, University of Munich, Munich, Germany. · Integrated Information Sciences, Novartis Pharma AG, Basel, Switzerland. · Oncology Global Development/Biometrics and Data Management, Novartis Institutes for Biomedical Research, Cambridge, MA, USA. · Translational Medicine/Biomarker Development, Novartis Institutes for Biomedical Research, Cambridge, MA, USA and. · Translational Medicine/Autoimmunity, Novartis Institutes for Biomedical Research, Basel, Switzerland. · Translational Medicine/Autoimmunity, Novartis Institutes for Biomedical Research, Basel, Switzerland · Pubmed 26268815
  • University of California, San Francisco. · Harvard Vanguard Medical Associates, Atrius Health, Somerville, Massachusetts. · University of California, San Francisco. · Brigham & Women's Hospital, Boston, Massachusetts. · University of British Columbia, Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada. · Boston University School of Medicine, Boston, Massachusetts. · University of Alabama at Birmingham, Palo Alto, California. · Stanford University Medical Center, Palo Alto, California. · American College of Rheumatology, Atlanta, Georgia. · Geisinger Medical Center, Danville, Pennsylvania. · Pubmed 27564778
  • Pfizer Inc, Groton, CT, USA. · Pfizer Inc, Groton, CT, USA. · Metroplex Clinical Research Center, Dallas, TX, USA. · University of Genoa, Italy. · Stanford University, Stanford, CA, USA. · Hospital Clinico Universitario, Santiago de Compostela, Spain. · Albany Medical College, Albany, NY, USA. · Seoul National University College of Medicine, Seoul, Republic of Korea. · Instituto Nacional de Ciencias Médicas y Nutrición-Salvador Zubirán, Mexico City, Mexico. · Pubmed 27156561
  • Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. · Division of Rheumatology, University of Nebraska Medical Center, Omaha, USA. · Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, Illinois, USA. · Center for Genomics and Human Genetics, Feinstein Institute Medical Research, North Shore LIJ Health System, New York, New York, USA. · Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama, USA. · Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Division of Rheumatology and Immunology, Duke University, Durham, USA. · Divisions of Rheumatology and Allergy, Johns Hopkins University, Baltimore, USA. · Division of Rheumatology and Allergy-Clinical Immunology, North Shore-LIJ Health System, Lake success, New York, USA. · Division of Immunology and Rheumatology, Stanford University, Stanford, California, USA. · Division of Rheumatology, University of Colorado Denver, Denver, USA. · Division of Rheumatology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. · Pubmed 26546586
2015
  • Department of Microbiology and Immunology, Stanford University, Stanford, CA, 94305, USA. · Division of Immune Monitoring and Biomarker Development, Aduro BioTech, Inc., Berkeley, CA, 94710, USA. · Department of Medicine, Stanford University, Stanford, CA, 94305, USA. · Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA, 94305, USA. · Department of Microbiology and Immunology, Stanford University, Stanford, CA, 94305, USA. · Department of Microbiology and Immunology, Stanford University, Stanford, CA, 94305, USA. · Department of Microbiology and Immunology, Stanford University, Stanford, CA, 94305, USA. · Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA, 94305, USA. · Department of Medicine, Stanford University, Stanford, CA, 94305, USA. · Department of Medicine, Stanford University, Stanford, CA, 94305, USA. · Division of Immune Monitoring and Biomarker Development, Aduro BioTech, Inc., Berkeley, CA, 94710, USA. · Department of Medicine, Stanford University, Stanford, CA, 94305, USA. · Pubmed 25981462
  • From the Division of Rheumatology, Stanford University, Palo Alto; Immunology, and Biostatistics, Janssen Research and Development LLC, La Jolla, California; Immunology, Janssen Research and Development, LLC, Spring House; Medical Affairs, Janssen Scientific Affairs LLC, Horsham, Pennsylvania; Quantitative Sciences, Janssen Research and Development LLC, Titusville, New Jersey, USA.M.C. Genovese, MD, Division of Rheumatology, Stanford University; E. Hsia, MD; S.M. Belkowski, PhD, Immunology, Janssen Research and Development LLC; C. Chien, PhD, Quantitative Sciences, Janssen Research and Development LLC; T. Masterson, MS; R.L. Thurmond, PhD; C.L. Manthey, PhD, Immunology, Janssen Research and Development LLC; X. Yan, PhD, Quantitative Sciences, Janssen Research and Development LLC; T. Ge, PhD, Biostatistics, Janssen Research and Development LLC; C. Franks, BS, Immunology, Janssen Research and Development LLC; A. Greenspan, MD, Medical Affairs, Janssen Scientific Affairs LLC. · From the Division of Rheumatology, Stanford University, Palo Alto; Immunology, and Biostatistics, Janssen Research and Development LLC, La Jolla, California; Immunology, Janssen Research and Development, LLC, Spring House; Medical Affairs, Janssen Scientific Affairs LLC, Horsham, Pennsylvania; Quantitative Sciences, Janssen Research and Development LLC, Titusville, New Jersey, USA.M.C. Genovese, MD, Division of Rheumatology, Stanford University; E. Hsia, MD; S.M. Belkowski, PhD, Immunology, Janssen Research and Development LLC; C. Chien, PhD, Quantitative Sciences, Janssen Research and Development LLC; T. Masterson, MS; R.L. Thurmond, PhD; C.L. Manthey, PhD, Immunology, Janssen Research and Development LLC; X. Yan, PhD, Quantitative Sciences, Janssen Research and Development LLC; T. Ge, PhD, Biostatistics, Janssen Research and Development LLC; C. Franks, BS, Immunology, Janssen Research and Development LLC; A. Greenspan, MD, Medical Affairs, Janssen Scientific Affairs LLC. · Pubmed 26233509
  • Isis Pharmaceuticals, Inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA. · Isis Pharmaceuticals, Inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA. · Isis Pharmaceuticals, Inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA. · Isis Pharmaceuticals, Inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA. · Stanford University, 1000 Welch Rd Palo, Alto, CA, 94304, USA. · Pubmed 25885521
  • Stanford University Medical Center, Palo Alto, California. · Institute of Rheumatology, Prague, Czech Republic. · Poznan University of Medical Sciences, Poznan, Poland. · MD Research, Naples, Florida. · Altoona Center for Clinical Research, Duncansville, Pennsylvania. · Celgene Corporation, Warren, New Jersey. · Suncoast Clinical Research, New Port Richey, Florida. · Pubmed 25779750
  • Stanford University Medical Center, Palo Alto, California. · Metroplex Clinical Research Center, Dallas, Texas. · Altoona Center for Clinical Research, Duncansville, Pennsylvania. · Rheumatology and Osteoporosis Outpatient Clinic, Warsaw, Poland. · Sanofi, Prague, Czech Republic. · Sanofi, Bridgewater, New Jersey. · Regeneron Pharmaceuticals, Tarrytown, New York. · Leiden University Medical Centre, Leiden, The Netherlands. · Pubmed 25733246
  • The Rebecca MacDonald Centre for Arthritis & Autoimmune Disease, Mount Sinai Hospital, Toronto, Ontario, Canada. · Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK. · Veszprém Csolnoky Ferenc County Hospital, Veszprém, Hungary. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Incyte Corporation, Wilmington, Delaware, USA. · Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA. · Pubmed 25431052
  • Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. · Department of Medicine, Stanford University, Stanford, California, USA. · AstraZeneca R&D, Macclesfield, UK. · Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, Russian Federation. · Formerly-AstraZeneca R&D, Boston, Massachusetts, USA. · Department of Rheumatology, University Hospital (MHAT) St. Ivan Rilski, Sofia, Bulgaria. · Institute of Rheumatology, Charles University, Prague, Czech Republic. · Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Pubmed 25074688
  • Stanford University, Rheumatology, 1000 Welch Road #203, Palo Alto, California 94304, USA. · Pubmed 26429208
2014
  • Division of Immunology and Rheumatology, Stanford University Medical Center, Stanford, USA. · Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA. · Department of Medicine, UCLA, Los Angeles, California, USA. · Houston Institute for Clinical Research, Houston, USA. · Division of Rheumatology, University of South Florida Health, Tampa, Florida, USA. · Department of Rheumatology, Southend University Hospital, Westcliff-on-Sea, UK. · UCB Pharma, Raleigh, USA. · William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Service et Pôle de Rhumatologie, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. · UCB Pharma, Slough, UK. · Pubmed 24641941
  • Stanford University, Palo Alto, California. · Pubmed 24623718
  • Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands. · Division of Rheumatology, Department of Medicine, University of Texas Southwestern Medical Center and Metroplex Clinical Research Center, Dallas, Texas, USA. · Department of Research and Development, Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA. · Department of Research and Development, Sanofi, Bridgewater, New Jersey, USA. · Department of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, California, USA. · Pubmed 24297381
2013
  • Division of Immunology and Rheumatology, Stanford University Medical Center, , Palo Alto, California 94304, USA. · Pubmed 23599435
  • Stanford University, Palo Alto, California 94304, USA. · Pubmed 23359344
  • Department of Rheumatology, Stanford University, Palo Alto, California 94304, USA. · Pubmed 22730366
  • Division of Rheumatology, Stanford University Medical Center, Palo Alto, CA 94304, USA. · Pubmed 23457383
  • Division of Immunology and Rheumatology, Stanford University, , Palo Alto, CA 94304, USA. · Pubmed 23268367
2012
  • Division of Immunology and Rheumatology, Stanford University, Palo Alto, CA 94304, USA. · Pubmed 22798265
  • Stanford University, Palo Alto, CA, USA. · Pubmed 22505702
2011
  • Stanford University, Palo Alto, California 94304, USA. · Pubmed 21618201
  • Stanford University, Palo Alto, California, USA. · Pubmed 21452293
  • Division of Immunology and Rheumatology, Stanford University, Palo Alto, California, USA. · Pubmed 21279990
  • Division of Immunology and Rheumatology,Stanford University, 1000 Welch Road #203, Palo Alto, CA 94304, USA. · Pubmed 21285160
2010
  • Stanford University, Palo Alto, California 94304, USA. genovese@stanford · Pubmed 20131262
2009
  • Stanford University School of Medicine, Palo Alto, California, USA. · Pubmed 19155233
2008
  • Division of Rheumatology, Stanford University Medical Center, Palo Alto, California 94304, USA. · Pubmed 18821691
  • Division of Rheumatology, Stanford University, Stanford, California 94304, USA. · Pubmed 18759293
  • Stanford University, Division of Immunology and Rheumatology, 1000 Welch Road #203, Palo Alto, CA 94304, USA. · Pubmed 17921185
2016
  • From the Stanford University Medical Center, Palo Alto, CA (M.C.G.); Albany Medical College, Albany, NY ( J.K.); Rheumazentrum Favoriten (O.Z.) and the Medical University of Vienna ( J.S.S.) - both in Vienna; East Penn Rheumatology, Bethlehem, PA (C.L.); Rheumatology Clinic, MAK-MED, Nadarzyn, Poland (M.K.); and Eli Lilly, Indianapolis (L.X., S.D.B., A.E.K., T.E.C., T.P.R., W.L.M., S.B., D.E.S.). · Pubmed 27028914
  • From Immunology and Rheumatology, University of Toronto and Mount Sinai Hospital, Toronto, Ontario, Canada; Immunology and Rheumatology, Stanford University, Palo Alto, California; Janssen Global Services LLC, Malvern, Pennsylvania, USA; Biostatistics, Janssen Research & Development LLC, Malvern; Biologics Clinical Pharmacology, and Immunology, Janssen Research & Development LLC, Spring House, Pennsylvania, USA; Rheumatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA; Rheumatology, Cabrini Medical Centre, Malvern, Australia; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.E.C. Keystone, MD, FRCP(C), Immunology and Rheumatology, University of Toronto and Mount Sinai Hospital; M.C. Genovese, MD, Immunology and Rheumatology, Stanford University; S. Hall, MBBS, FRACP, Rheumatology, Cabrini Medical Centre; S.C. Bae, MD, PhD, MPH, Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases; C. Han, PhD, Janssen Global Services LLC; T.A. Gathany, MEd, Janssen Global Services LLC; S. Xu, MS, Biostatistics, Janssen Research & Development LLC; Y. Zhou, PhD, Biostatistics, Janssen Research & Development LLC; J.H. Leu, PhD, Biologics Clinical Pharmacology, Janssen Research & Development LLC; E.C. Hsia, MD, Immunology, Janssen Research & Development LLC, and Rheumatology, University of Pennsylvania School of Medicine. · From Immunology and Rheumatology, University of Toronto and Mount Sinai Hospital, Toronto, Ontario, Canada; Immunology and Rheumatology, Stanford University, Palo Alto, California; Janssen Global Services LLC, Malvern, Pennsylvania, USA; Biostatistics, Janssen Research & Development LLC, Malvern; Biologics Clinical Pharmacology, and Immunology, Janssen Research & Development LLC, Spring House, Pennsylvania, USA; Rheumatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA; Rheumatology, Cabrini Medical Centre, Malvern, Australia; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.E.C. Keystone, MD, FRCP(C), Immunology and Rheumatology, University of Toronto and Mount Sinai Hospital; M.C. Genovese, MD, Immunology and Rheumatology, Stanford University; S. Hall, MBBS, FRACP, Rheumatology, Cabrini Medical Centre; S.C. Bae, MD, PhD, MPH, Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases; C. Han, PhD, Janssen Global Services LLC; T.A. Gathany, MEd, Janssen Global Services LLC; S. Xu, MS, Biostatistics, Janssen Research & Development LLC; Y. Zhou, PhD, Biostatistics, Janssen Research & Development LLC; J.H. Leu, PhD, Biologics Clinical Pharmacology, Janssen Research & Development LLC; E.C. Hsia, MD, Immunology, Janssen Research & Development LLC, and Rheumatology, University of Pennsylvania School of Medicine. · Pubmed 26669912
2015
  • From the *Stanford University Medical Center, Palo Alto, CA; †NYU School of Medicine, New York, NY; ‡Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom; §Private Practice, Memphis, TN; and ∥Eli Lilly and Company, Indianapolis, IN. · Pubmed 26203826
2014
  • From Stanford University, Palo Alto, California, USA; Leiden University Medical Center, Leiden, The Netherlands; University of Toronto, Toronto, Ontario, Canada; Centro Medico Privado de Reumatologia, San Miguel de Tucuman, Argentina; Centre Hospitalier Régional, Orleans, France; University of California, San Diego, La Jolla, California; Austin Rheumatology Research PA, Austin, Texas; (formerly) AstraZeneca, Wilmington, Delaware, USA; AstraZeneca, Macclesfield, UK; Arthritis Associates, Orlando, Florida; Brigham and Women's Hospital, Boston, Massachusetts, USA.M.C. Genovese, MD, Stanford University; D.M. van der Heijde, MD, PhD, Leiden University Medical Center; E.C. Keystone, MD, University of Toronto; A.J. Spindler, MD, Centro Medico Privado de Reumatologia; C. Benhamou, MD, Centre Hospitalier Régional; A. Kavanaugh, MD, University of California, San Diego; E. Fudman, MD, Austin Rheumatology Research PA; K. Lampl, MD; C. O'Brien, MD, PhD, (formerly) AstraZeneca; E.L. Duffield, MSc, AstraZeneca, UK; J. Poiley, MD, Arthritis Associates; M.E. Weinblatt, MD, Brigham and Women's Hospital. · From Stanford University, Palo Alto, California, USA; Leiden University Medical Center, Leiden, The Netherlands; University of Toronto, Toronto, Ontario, Canada; Centro Medico Privado de Reumatologia, San Miguel de Tucuman, Argentina; Centre Hospitalier Régional, Orleans, France; University of California, San Diego, La Jolla, California; Austin Rheumatology Research PA, Austin, Texas; (formerly) AstraZeneca, Wilmington, Delaware, USA; AstraZeneca, Macclesfield, UK; Arthritis Associates, Orlando, Florida; Brigham and Women's Hospital, Boston, Massachusetts, USA.M.C. Genovese, MD, Stanford University; D.M. van der Heijde, MD, PhD, Leiden University Medical Center; E.C. Keystone, MD, University of Toronto; A.J. Spindler, MD, Centro Medico Privado de Reumatologia; C. Benhamou, MD, Centre Hospitalier Régional; A. Kavanaugh, MD, University of California, San Diego; E. Fudman, MD, Austin Rheumatology Research PA; K. Lampl, MD; C. O'Brien, MD, PhD, (formerly) AstraZeneca; E.L. Duffield, MSc, AstraZeneca, UK; J. Poiley, MD, Arthritis Associates; M.E. Weinblatt, MD, Brigham and Women's Hospital. · Pubmed 25225285
  • From Stanford University, Palo Alto, California, USA; Universidad Autónoma de Chihuahua, Chihuahua; Unidad Reumatologica Las Americas S.C.P., Mérida, Mexico; Instituto De Ginecologia Y Reproduccion, Lima, Peru; Organización Médica de Investigación, Buenos Aires, Argentina; Pontificial Catholic University School of Medicine, Porto Alegre, Brazil; Physician Research Collaboration, Lincoln, Nebraska, USA; University of Queensland, Brisbane, Queensland, Australia; Centro De Especialidades Médicas/Universidad Marista, Mérida, Mexico; Box Arthritis and Rheumatology of the Carolinas, Charlotte, North Carolina; Low Country Rheumatology, Charleston, South Carolina, USA; Institute of Rheumatology, Moscow, Russia; Service et Pôle de Rhumatologie, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium; Bristol-Myers Squibb, Princeton, New Jersey, USA; and Schlosspark-Klinik, Teaching Hospital of the Charité University Medicine Berlin, Berlin, Germany. · Pubmed 24584926
  • From Stanford University, Palo Alto, California, USA; Pôle de Recherche en Rhumatologie, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain and Cliniques Universitaires Saint-Luc, Brussels, Belgium; Novartis Pharma AG, Basel, Switzerland; NZOZ Centrum Medyczne Artur Racewicz, Bialystok, Poland; Medical Plus, Uherske Hradiste, Czech Republic; Arthritis Clinic, Jackson, Tennessee, USA; Konkuk University Medical Center, Seoul, South Korea; Health Research of Oklahoma, Oklahoma City, Oklahoma, USA; Centre for Inflammatory Joint Diseases, Munich, Germany; Kobe-Konan Yamate Clinic, Kobe, Japan; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA. · Pubmed 24429175
  • From the University of Alberta, Edmonton, Alberta; Augurex Life Sciences Corp., North Vancouver, British Columbia; Mount Sinai Hospital, Toronto, Ontario, Canada; Quest Diagnostics Nichols Institute, San Juan Capistrano; Stanford University Medical Center, Palo Alto, California; Hospital for Special Surgery, New York, New York; Brigham and Women's Hospital, Boston, Massachusetts, USA; Vrije Universiteit University Medical Center; Academic Medical Center/University of Amsterdam; Jan van Breemen Research Institute, Reade organization, Amsterdam; the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; University of Cambridge, Cambridge; GlaxoSmithKline, Stevenage, UK.W.P. Maksymowych, MD, Professor of Medicine, University of Alberta; S.J. Naides, MD, Quest Diagnostics Nichols Institute; V. Bykerk, MD, Hospital for Special Surgery; K.A. Siminovitch, MD, Mount Sinai Hospital; D. van Schaardenburg, MD, Jan van Breemen Research Institute; M. Boers, MD, Vrije Universiteit University Medical Center; R. Landewé, MD, Academic Medical Center/University of Amsterdam; D. van der Heijde, MD, Department of Rheumatology, Leiden University Medical Center; P-P. Tak, MD, Academic Medical Center/University of Amsterdam, University of Cambridge, GlaxoSmithKline; M.C. Genovese, MD, Stanford University Medical Center; M.E. Weinblatt, MD, Brigham and Women's Hospital; E.C. Keystone, MD, Mount Sinai Hospital; O.S. Zhukov, MS; R.W. Abolhosn, BS; J.M. Popov, MD, PhD, Quest Diagnostics Nichols Institute; K. Britsemmer, MD, Jan van Breemen Research Institute; A.W. van Kuijk, MD, Academic Medical Center/University of Amsterdam; A. Marotta, PhD, Augurex Life Sciences Corp. · From the University of Alberta, Edmonton, Alberta; Augurex Life Sciences Corp., North Vancouver, British Columbia; Mount Sinai Hospital, Toronto, Ontario, Canada; Quest Diagnostics Nichols Institute, San Juan Capistrano; Stanford University Medical Center, Palo Alto, California; Hospital for Special Surgery, New York, New York; Brigham and Women's Hospital, Boston, Massachusetts, USA; Vrije Universiteit University Medical Center; Academic Medical Center/University of Amsterdam; Jan van Breemen Research Institute, Reade organization, Amsterdam; the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; University of Cambridge, Cambridge; GlaxoSmithKline, Stevenage, UK.W.P. Maksymowych, MD, Professor of Medicine, University of Alberta; S.J. Naides, MD, Quest Diagnostics Nichols Institute; V. Bykerk, MD, Hospital for Special Surgery; K.A. Siminovitch, MD, Mount Sinai Hospital; D. van Schaardenburg, MD, Jan van Breemen Research Institute; M. Boers, MD, Vrije Universiteit University Medical Center; R. Landewé, MD, Academic Medical Center/University of Amsterdam; D. van der Heijde, MD, Department of Rheumatology, Leiden University Medical Center; P-P. Tak, MD, Academic Medical Center/University of Amsterdam, University of Cambridge, GlaxoSmithKline; M.C. Genovese, MD, Stanford University Medical Center; M.E. Weinblatt, MD, Brigham and Women's Hospital; E.C. Keystone, MD, Mount Sinai Hospital; O.S. Zhukov, MS; R.W. Abolhosn, BS; J.M. Popov, MD, PhD, Quest Diagnostics Nichols Institute; K. Britsemmer, MD, Jan van Breemen Research Institute; A.W. van Kuijk, MD, Academic Medical Center/University of Amsterdam; A. Marotta, PhD, Augurex Life Sciences Corp. · Pubmed 25128504
2013
  • Division of Immunology and Rheumatology, Stanford University, 1000 Welch Rd #203, Palo Alto, CA 94304, USA. · Pubmed 23297340
2009
  • Department of Medicine, Division of Immunology & Rheumatology, Stanford University, Stanford, CA 94305, USA. · Pubmed 19460157
2007
  • Division of Immunology and Rheumatology, Stanford University, Palo Alto, California 94304, USA. · Pubmed 17977486
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 84 total) written by Dr. Mark Genovese about Rheumatoid Arthritis:

  • Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials. 2017
  • Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study. 2017
  • Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease-Modifying Antirheumatic Drugs in the Treatment of Moderate-to-Severe Rheumatoid Arthritis. 2017
  • Effects of Baricitinib on Lipid, Apolipoprotein, and Lipoprotein Particle Profiles in a Phase IIb Study of Patients With Active Rheumatoid Arthritis. 2017
  • Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON). 2017
  • Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate. 2017
  • Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis. 2017
  • Low immunogenicity of tocilizumab in patients with rheumatoid arthritis. 2017
  • Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis. 2017
  • Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial. 2016
Show List of Full Article Records
Google Searches

Learn more about Dr. Mark Genovese using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Stanford University
Affiliation Timeline What is this?
Stanford University
2017
  • Department of Musculoskeletal Biology, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK. · Department of Rheumatology, University of South Florida, Tampa, FL. · Medicine/Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Department of Rheumatology, Addenbrookes Hospital, Cambridge. · Roche Products Limited, Welwyn Garden City, UK. · Department of Internal Medicine, University of Cologne, Cologne, Germany. · Department of Medicine, Karolinska Institute, Stockholm, Sweden. · Division of Rheumatology, Stanford University Medical Center, Palo Alto, CA, USA. · Pubmed 28013198
  • Metroplex Clinical Research Center, Dallas, Texas, USA. · Stanford University School of Medicine, Palo Alto, California, USA. · CREATE Centre, Section of Rheumatology, Institute of Infection and Immunity, Cardiff University, Cardiff, UK. · Rheumatology Division, Cruces University Hospital, OSI EE-Cruces and Biocruces Health Research Institute, Vizcaya, Spain. · Arthritis and Rheumatism Associates, Wheaton, Maryland, USA. · Na Slupi 4 Praha 2, Praha, Czech Republic. · Instituto de Investigación Hospital 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain. · Advanced Arthritis Care & Research, Scottsdale, Arizona, USA. · Department of Rheumatology and Clinical Immunology, Poznań University of Medical Sciences, Poznań, Poland. · Amgen Inc., Thousand Oaks, California, USA. · RANA Clinical Research Center, Huntsville, Alabama, USA. · Pubmed 28584187
  • Stanford University, Palo Alto, California. · Desert Medical Advances, Palm Desert, California. · Health Research of Oklahoma, Oklahoma City. · ARS Rheumatica, Warsaw, Poland. · Altoona Center for Clinical Research, Duncansville, Pennsylvania. · Astellas Pharma Global Development, Northbrook, Illinois. · Centro de Investigación Clínica de Morelia SC, Morelia, Mexico. · Pubmed 28118538
  • Albany Medical College, Albany, New York. · Stanford University Medical Center, Palo Alto, California. · University of Toronto, Toronto, Ontario, Canada. · University of Oxford, Oxford, UK. · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 28029752
  • Medical University of Vienna and Hietzing Hospital, Vienna, Austria. · Albany Medical College, Albany, New York, USA. · Eli Lilly and Company, Indianapolis, Indiana, USA. · University of New South Wales, Sydney, New South Wales, Australia. · Divisions of Rheumatology, Ophthalmology and Immunology, Valme University Hospital, Sevilla, Spain. · Stanford University Medical Center, Palo Alto, California, USA. · Lapeyronie Hospital, Montpellier University, Montpellier, France. · Pubmed 27799159
  • Altoona Center for Clinical Research, Duncansville, Pennsylvania. · Hospital Civil de Guadalajara, Guadalajara, Mexico. · Arthritis Associates, Orlando, Florida. · Stanford University, Palo Alto, California. · Astellas Pharma Global Development, Northbrook, Illinois. · ARS Rheumatica, Warsaw, Poland. · Pubmed 27748083
  • Stanford University Medical Center, Palo Alto, California. · Albany Medical College, Albany, New York. · Karolinska Institute, Stockholm, Sweden (current address: Amsterdam Rheumatology and Immunology Center, Academic Medical Center, Amsterdam, The Netherlands). · University of Berlin, Berlin, Germany. · Durand University Hospital, Buenos Aires, Argentina. · Genentech, Inc., South San Francisco, California. · Roche Products Ltd., Welwyn Garden City, UK. · Pubmed 28597609
  • Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Free University and Humboldt University of Berlin, Berlin, Germany. · Cardiff University, Cardiff, UK. · Altoona Center for Clinical Research, Duncansville, Pennsylvania, USA. · Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Osaka, Japan. · Division of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, Osaka, Japan. · Genentech, Inc., South San Francisco, California, USA. · Chugai Pharmaceutical Co., Ltd., Tokyo, Japan. · Roche Products Limited, Welwyn Garden City, UK. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · Roche Innovation Center, New York, New York, USA. · Roche Pharma Research and Early Development, Roche Innovation Center, Basel, Switzerland. · Roche Pharma Research and Early Development, Roche Innovation Center, Munich, Germany. · Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, California, USA. · Pubmed 28007755
  • Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Free University and Humboldt University of Berlin, Berlin, Germany. · Clinical Immunology and Rheumatology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. · Division of Immunology and Rheumatology, Stanford University, Palo Alto, California, USA. · Immunology Clinical Development, AbbVie, North Chicago, Illinois, USA. · Clinical Pharmacology and Pharmacometrics, AbbVie, North Chicago, Illinois, USA. · Data and Statistical Sciences, AbbVie, North Chicago, Illinois, USA. · Pubmed 27338778
2016
  • Stanford University Medical Center, Palo Alto, CA, USA. · Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, 94303, USA. · , Mailing address: 306 Ramona Road, Portola Valley, California, 94028, USA. · Optum, Lincoln, RI, USA. · Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA. · Sanofi Genzyme, Bridgewater, NJ, USA. · now with Novartis, East Hanover, NJ, USA. · Leiden University Medical Centre, Leiden, The Netherlands. · Stanford University Medical Center, Palo Alto, CA, USA. · Pubmed 27600829
  • Stanford University School of Medicine, Palo Alto, California. · Medical University of Vienna and Hietzing Hospital, Vienna, Austria. · Brigham and Women's Hospital, Boston, Massachusetts. · Charité-Universitätsmedizin Berlin, Berlin, Germany. · AbbVie Deutschland, Ludwigshafen, Germany. · AbbVie, North Chicago, Illinois. · Pubmed 27390150
  • Division of Rheumatology, Stanford University, Palo Alto, CA, USA. · Unit for Clinical Therapy Research, Inflammatory Diseases, Karolinska Institute, Stockholm, Sweden. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, 500 Arcola Drive, F5352, Collegeville, PA, 19426, USA. · Pfizer Inc, 500 Arcola Drive, F5352, Collegeville, PA, 19426, USA. · Pubmed 27334658
  • Schlosspark-Klinik University Medicine, Berlin, Germany. · University Medicine Berlin, Berlin, 14059, Germany. · Johns Hopkins University, Baltimore, MD, USA. · Metroplex Clinical Research Center, Dallas, TX, USA. · University of Alabama at Birmingham, Birmingham, AL, USA. · Bristol-Myers Squibb, Princeton, NJ, USA. · Stanford University, Palo Alto, CA, USA. · Pubmed 27229685
  • Division of Immunology and Rheumatology, Stanford University, Palo Alto, California, USA. · Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA. · Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet-Glostrup, University of Copenhagen, Copenhagen, Denmark. · Pubmed 27084959
  • From the Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, California; Eli Lilly and Company, Indianapolis, Indiana; Bristol-Myers Squibb, Princeton, New Jersey, USA.M.C. Genovese, MD, James W. Raitt Professor of Medicine, Co-Chief of Division of Immunology and Rheumatology, Stanford University School of Medicine; D.K. Braun, MD, Medical Fellow; Eli Lilly and Company; J.S. Erickson, PhD, Statistician, Eli Lilly and Company; P.Y. Berclaz, MD, Senior Medical Director, Eli Lilly and Company; M.P. Heffernan, MD, Senior Medical Director, Eli Lilly and Company; H. Carlier, MD, Senior Medical Advisor, Eli Lilly and Company, Indianapolis; S. Banerjee, MD, Bristol-Myers Squibb. · From the Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, California; Eli Lilly and Company, Indianapolis, Indiana; Bristol-Myers Squibb, Princeton, New Jersey, USA.M.C. Genovese, MD, James W. Raitt Professor of Medicine, Co-Chief of Division of Immunology and Rheumatology, Stanford University School of Medicine; D.K. Braun, MD, Medical Fellow; Eli Lilly and Company; J.S. Erickson, PhD, Statistician, Eli Lilly and Company; P.Y. Berclaz, MD, Senior Medical Director, Eli Lilly and Company; M.P. Heffernan, MD, Senior Medical Director, Eli Lilly and Company; H. Carlier, MD, Senior Medical Advisor, Eli Lilly and Company, Indianapolis; S. Banerjee, MD, Bristol-Myers Squibb. · Pubmed 26669919
  • Stanford University, Palo Alto, California. · Karolinska Institute, Stockholm, Sweden. · Universidad Autónoma de Chihuahua, Chihuahua, Mexico. · Vertex Pharmaceuticals Incorporated, Boston, Massachusetts. · Pubmed 26473751
  • Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany. · Service et Pôle de Rhumatologie, Cliniques Universitaires Saint-Luc, and Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Rheumatology, Brussels, Belgium. · Department of Internal Medicine, City Clinical Hospital, Nizhny Novgorod, Russia. · Division of Rheumatology and Clinical Immunology, Stanford University, Stanford, CA, USA. · Division of Rheumatology and Clinical Immunology, Medizinische Klinik and Poliklinik IV, University of Munich, Munich, Germany. · Integrated Information Sciences, Novartis Pharma AG, Basel, Switzerland. · Oncology Global Development/Biometrics and Data Management, Novartis Institutes for Biomedical Research, Cambridge, MA, USA. · Translational Medicine/Biomarker Development, Novartis Institutes for Biomedical Research, Cambridge, MA, USA and. · Translational Medicine/Autoimmunity, Novartis Institutes for Biomedical Research, Basel, Switzerland. · Translational Medicine/Autoimmunity, Novartis Institutes for Biomedical Research, Basel, Switzerland · Pubmed 26268815
  • University of California, San Francisco. · Harvard Vanguard Medical Associates, Atrius Health, Somerville, Massachusetts. · University of California, San Francisco. · Brigham & Women's Hospital, Boston, Massachusetts. · University of British Columbia, Arthritis Research Centre of Canada, Vancouver, British Columbia, Canada. · Boston University School of Medicine, Boston, Massachusetts. · University of Alabama at Birmingham, Palo Alto, California. · Stanford University Medical Center, Palo Alto, California. · American College of Rheumatology, Atlanta, Georgia. · Geisinger Medical Center, Danville, Pennsylvania. · Pubmed 27564778
  • Pfizer Inc, Groton, CT, USA. · Pfizer Inc, Groton, CT, USA. · Metroplex Clinical Research Center, Dallas, TX, USA. · University of Genoa, Italy. · Stanford University, Stanford, CA, USA. · Hospital Clinico Universitario, Santiago de Compostela, Spain. · Albany Medical College, Albany, NY, USA. · Seoul National University College of Medicine, Seoul, Republic of Korea. · Instituto Nacional de Ciencias Médicas y Nutrición-Salvador Zubirán, Mexico City, Mexico. · Pubmed 27156561
  • Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. · Division of Rheumatology, University of Nebraska Medical Center, Omaha, USA. · Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, Illinois, USA. · Center for Genomics and Human Genetics, Feinstein Institute Medical Research, North Shore LIJ Health System, New York, New York, USA. · Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama, USA. · Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Division of Rheumatology and Immunology, Duke University, Durham, USA. · Divisions of Rheumatology and Allergy, Johns Hopkins University, Baltimore, USA. · Division of Rheumatology and Allergy-Clinical Immunology, North Shore-LIJ Health System, Lake success, New York, USA. · Division of Immunology and Rheumatology, Stanford University, Stanford, California, USA. · Division of Rheumatology, University of Colorado Denver, Denver, USA. · Division of Rheumatology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. · Pubmed 26546586
2015
  • Department of Microbiology and Immunology, Stanford University, Stanford, CA, 94305, USA. · Division of Immune Monitoring and Biomarker Development, Aduro BioTech, Inc., Berkeley, CA, 94710, USA. · Department of Medicine, Stanford University, Stanford, CA, 94305, USA. · Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA, 94305, USA. · Department of Microbiology and Immunology, Stanford University, Stanford, CA, 94305, USA. · Department of Microbiology and Immunology, Stanford University, Stanford, CA, 94305, USA. · Department of Microbiology and Immunology, Stanford University, Stanford, CA, 94305, USA. · Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA, 94305, USA. · Department of Medicine, Stanford University, Stanford, CA, 94305, USA. · Department of Medicine, Stanford University, Stanford, CA, 94305, USA. · Division of Immune Monitoring and Biomarker Development, Aduro BioTech, Inc., Berkeley, CA, 94710, USA. · Department of Medicine, Stanford University, Stanford, CA, 94305, USA. · Pubmed 25981462
  • From the Division of Rheumatology, Stanford University, Palo Alto; Immunology, and Biostatistics, Janssen Research and Development LLC, La Jolla, California; Immunology, Janssen Research and Development, LLC, Spring House; Medical Affairs, Janssen Scientific Affairs LLC, Horsham, Pennsylvania; Quantitative Sciences, Janssen Research and Development LLC, Titusville, New Jersey, USA.M.C. Genovese, MD, Division of Rheumatology, Stanford University; E. Hsia, MD; S.M. Belkowski, PhD, Immunology, Janssen Research and Development LLC; C. Chien, PhD, Quantitative Sciences, Janssen Research and Development LLC; T. Masterson, MS; R.L. Thurmond, PhD; C.L. Manthey, PhD, Immunology, Janssen Research and Development LLC; X. Yan, PhD, Quantitative Sciences, Janssen Research and Development LLC; T. Ge, PhD, Biostatistics, Janssen Research and Development LLC; C. Franks, BS, Immunology, Janssen Research and Development LLC; A. Greenspan, MD, Medical Affairs, Janssen Scientific Affairs LLC. · From the Division of Rheumatology, Stanford University, Palo Alto; Immunology, and Biostatistics, Janssen Research and Development LLC, La Jolla, California; Immunology, Janssen Research and Development, LLC, Spring House; Medical Affairs, Janssen Scientific Affairs LLC, Horsham, Pennsylvania; Quantitative Sciences, Janssen Research and Development LLC, Titusville, New Jersey, USA.M.C. Genovese, MD, Division of Rheumatology, Stanford University; E. Hsia, MD; S.M. Belkowski, PhD, Immunology, Janssen Research and Development LLC; C. Chien, PhD, Quantitative Sciences, Janssen Research and Development LLC; T. Masterson, MS; R.L. Thurmond, PhD; C.L. Manthey, PhD, Immunology, Janssen Research and Development LLC; X. Yan, PhD, Quantitative Sciences, Janssen Research and Development LLC; T. Ge, PhD, Biostatistics, Janssen Research and Development LLC; C. Franks, BS, Immunology, Janssen Research and Development LLC; A. Greenspan, MD, Medical Affairs, Janssen Scientific Affairs LLC. · Pubmed 26233509
  • Isis Pharmaceuticals, Inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA. · Isis Pharmaceuticals, Inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA. · Isis Pharmaceuticals, Inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA. · Isis Pharmaceuticals, Inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA. · Stanford University, 1000 Welch Rd Palo, Alto, CA, 94304, USA. · Pubmed 25885521
  • Stanford University Medical Center, Palo Alto, California. · Institute of Rheumatology, Prague, Czech Republic. · Poznan University of Medical Sciences, Poznan, Poland. · MD Research, Naples, Florida. · Altoona Center for Clinical Research, Duncansville, Pennsylvania. · Celgene Corporation, Warren, New Jersey. · Suncoast Clinical Research, New Port Richey, Florida. · Pubmed 25779750
  • Stanford University Medical Center, Palo Alto, California. · Metroplex Clinical Research Center, Dallas, Texas. · Altoona Center for Clinical Research, Duncansville, Pennsylvania. · Rheumatology and Osteoporosis Outpatient Clinic, Warsaw, Poland. · Sanofi, Prague, Czech Republic. · Sanofi, Bridgewater, New Jersey. · Regeneron Pharmaceuticals, Tarrytown, New York. · Leiden University Medical Centre, Leiden, The Netherlands. · Pubmed 25733246
  • The Rebecca MacDonald Centre for Arthritis & Autoimmune Disease, Mount Sinai Hospital, Toronto, Ontario, Canada. · Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK. · Veszprém Csolnoky Ferenc County Hospital, Veszprém, Hungary. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Incyte Corporation, Wilmington, Delaware, USA. · Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA. · Pubmed 25431052
  • Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. · Department of Medicine, Stanford University, Stanford, California, USA. · AstraZeneca R&D, Macclesfield, UK. · Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, Russian Federation. · Formerly-AstraZeneca R&D, Boston, Massachusetts, USA. · Department of Rheumatology, University Hospital (MHAT) St. Ivan Rilski, Sofia, Bulgaria. · Institute of Rheumatology, Charles University, Prague, Czech Republic. · Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Pubmed 25074688
  • Stanford University, Rheumatology, 1000 Welch Road #203, Palo Alto, California 94304, USA. · Pubmed 26429208
2014
  • Division of Immunology and Rheumatology, Stanford University Medical Center, Stanford, USA. · Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA. · Department of Medicine, UCLA, Los Angeles, California, USA. · Houston Institute for Clinical Research, Houston, USA. · Division of Rheumatology, University of South Florida Health, Tampa, Florida, USA. · Department of Rheumatology, Southend University Hospital, Westcliff-on-Sea, UK. · UCB Pharma, Raleigh, USA. · William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Service et Pôle de Rhumatologie, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. · UCB Pharma, Slough, UK. · Pubmed 24641941
  • Stanford University, Palo Alto, California. · Pubmed 24623718
  • Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands. · Division of Rheumatology, Department of Medicine, University of Texas Southwestern Medical Center and Metroplex Clinical Research Center, Dallas, Texas, USA. · Department of Research and Development, Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA. · Department of Research and Development, Sanofi, Bridgewater, New Jersey, USA. · Department of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, California, USA. · Pubmed 24297381
2013
  • Division of Immunology and Rheumatology, Stanford University Medical Center, , Palo Alto, California 94304, USA. · Pubmed 23599435
  • Stanford University, Palo Alto, California 94304, USA. · Pubmed 23359344
  • Department of Rheumatology, Stanford University, Palo Alto, California 94304, USA. · Pubmed 22730366
  • Division of Rheumatology, Stanford University Medical Center, Palo Alto, CA 94304, USA. · Pubmed 23457383
  • Division of Immunology and Rheumatology, Stanford University, , Palo Alto, CA 94304, USA. · Pubmed 23268367
2012
  • Division of Immunology and Rheumatology, Stanford University, Palo Alto, CA 94304, USA. · Pubmed 22798265
  • Stanford University, Palo Alto, CA, USA. · Pubmed 22505702
2011
  • Stanford University, Palo Alto, California 94304, USA. · Pubmed 21618201
  • Stanford University, Palo Alto, California, USA. · Pubmed 21452293
  • Division of Immunology and Rheumatology, Stanford University, Palo Alto, California, USA. · Pubmed 21279990
  • Division of Immunology and Rheumatology,Stanford University, 1000 Welch Road #203, Palo Alto, CA 94304, USA. · Pubmed 21285160
2010
  • Stanford University, Palo Alto, California 94304, USA. genovese@stanford · Pubmed 20131262
2009
  • Stanford University School of Medicine, Palo Alto, California, USA. · Pubmed 19155233
2008
  • Division of Rheumatology, Stanford University Medical Center, Palo Alto, California 94304, USA. · Pubmed 18821691
  • Division of Rheumatology, Stanford University, Stanford, California 94304, USA. · Pubmed 18759293
  • Stanford University, Division of Immunology and Rheumatology, 1000 Welch Road #203, Palo Alto, CA 94304, USA. · Pubmed 17921185
2016
  • From the Stanford University Medical Center, Palo Alto, CA (M.C.G.); Albany Medical College, Albany, NY ( J.K.); Rheumazentrum Favoriten (O.Z.) and the Medical University of Vienna ( J.S.S.) - both in Vienna; East Penn Rheumatology, Bethlehem, PA (C.L.); Rheumatology Clinic, MAK-MED, Nadarzyn, Poland (M.K.); and Eli Lilly, Indianapolis (L.X., S.D.B., A.E.K., T.E.C., T.P.R., W.L.M., S.B., D.E.S.). · Pubmed 27028914
  • From Immunology and Rheumatology, University of Toronto and Mount Sinai Hospital, Toronto, Ontario, Canada; Immunology and Rheumatology, Stanford University, Palo Alto, California; Janssen Global Services LLC, Malvern, Pennsylvania, USA; Biostatistics, Janssen Research & Development LLC, Malvern; Biologics Clinical Pharmacology, and Immunology, Janssen Research & Development LLC, Spring House, Pennsylvania, USA; Rheumatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA; Rheumatology, Cabrini Medical Centre, Malvern, Australia; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.E.C. Keystone, MD, FRCP(C), Immunology and Rheumatology, University of Toronto and Mount Sinai Hospital; M.C. Genovese, MD, Immunology and Rheumatology, Stanford University; S. Hall, MBBS, FRACP, Rheumatology, Cabrini Medical Centre; S.C. Bae, MD, PhD, MPH, Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases; C. Han, PhD, Janssen Global Services LLC; T.A. Gathany, MEd, Janssen Global Services LLC; S. Xu, MS, Biostatistics, Janssen Research & Development LLC; Y. Zhou, PhD, Biostatistics, Janssen Research & Development LLC; J.H. Leu, PhD, Biologics Clinical Pharmacology, Janssen Research & Development LLC; E.C. Hsia, MD, Immunology, Janssen Research & Development LLC, and Rheumatology, University of Pennsylvania School of Medicine. · From Immunology and Rheumatology, University of Toronto and Mount Sinai Hospital, Toronto, Ontario, Canada; Immunology and Rheumatology, Stanford University, Palo Alto, California; Janssen Global Services LLC, Malvern, Pennsylvania, USA; Biostatistics, Janssen Research & Development LLC, Malvern; Biologics Clinical Pharmacology, and Immunology, Janssen Research & Development LLC, Spring House, Pennsylvania, USA; Rheumatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA; Rheumatology, Cabrini Medical Centre, Malvern, Australia; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.E.C. Keystone, MD, FRCP(C), Immunology and Rheumatology, University of Toronto and Mount Sinai Hospital; M.C. Genovese, MD, Immunology and Rheumatology, Stanford University; S. Hall, MBBS, FRACP, Rheumatology, Cabrini Medical Centre; S.C. Bae, MD, PhD, MPH, Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases; C. Han, PhD, Janssen Global Services LLC; T.A. Gathany, MEd, Janssen Global Services LLC; S. Xu, MS, Biostatistics, Janssen Research & Development LLC; Y. Zhou, PhD, Biostatistics, Janssen Research & Development LLC; J.H. Leu, PhD, Biologics Clinical Pharmacology, Janssen Research & Development LLC; E.C. Hsia, MD, Immunology, Janssen Research & Development LLC, and Rheumatology, University of Pennsylvania School of Medicine. · Pubmed 26669912
2015
  • From the *Stanford University Medical Center, Palo Alto, CA; †NYU School of Medicine, New York, NY; ‡Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom; §Private Practice, Memphis, TN; and ∥Eli Lilly and Company, Indianapolis, IN. · Pubmed 26203826
2014
  • From Stanford University, Palo Alto, California, USA; Leiden University Medical Center, Leiden, The Netherlands; University of Toronto, Toronto, Ontario, Canada; Centro Medico Privado de Reumatologia, San Miguel de Tucuman, Argentina; Centre Hospitalier Régional, Orleans, France; University of California, San Diego, La Jolla, California; Austin Rheumatology Research PA, Austin, Texas; (formerly) AstraZeneca, Wilmington, Delaware, USA; AstraZeneca, Macclesfield, UK; Arthritis Associates, Orlando, Florida; Brigham and Women's Hospital, Boston, Massachusetts, USA.M.C. Genovese, MD, Stanford University; D.M. van der Heijde, MD, PhD, Leiden University Medical Center; E.C. Keystone, MD, University of Toronto; A.J. Spindler, MD, Centro Medico Privado de Reumatologia; C. Benhamou, MD, Centre Hospitalier Régional; A. Kavanaugh, MD, University of California, San Diego; E. Fudman, MD, Austin Rheumatology Research PA; K. Lampl, MD; C. O'Brien, MD, PhD, (formerly) AstraZeneca; E.L. Duffield, MSc, AstraZeneca, UK; J. Poiley, MD, Arthritis Associates; M.E. Weinblatt, MD, Brigham and Women's Hospital. · From Stanford University, Palo Alto, California, USA; Leiden University Medical Center, Leiden, The Netherlands; University of Toronto, Toronto, Ontario, Canada; Centro Medico Privado de Reumatologia, San Miguel de Tucuman, Argentina; Centre Hospitalier Régional, Orleans, France; University of California, San Diego, La Jolla, California; Austin Rheumatology Research PA, Austin, Texas; (formerly) AstraZeneca, Wilmington, Delaware, USA; AstraZeneca, Macclesfield, UK; Arthritis Associates, Orlando, Florida; Brigham and Women's Hospital, Boston, Massachusetts, USA.M.C. Genovese, MD, Stanford University; D.M. van der Heijde, MD, PhD, Leiden University Medical Center; E.C. Keystone, MD, University of Toronto; A.J. Spindler, MD, Centro Medico Privado de Reumatologia; C. Benhamou, MD, Centre Hospitalier Régional; A. Kavanaugh, MD, University of California, San Diego; E. Fudman, MD, Austin Rheumatology Research PA; K. Lampl, MD; C. O'Brien, MD, PhD, (formerly) AstraZeneca; E.L. Duffield, MSc, AstraZeneca, UK; J. Poiley, MD, Arthritis Associates; M.E. Weinblatt, MD, Brigham and Women's Hospital. · Pubmed 25225285
  • From Stanford University, Palo Alto, California, USA; Universidad Autónoma de Chihuahua, Chihuahua; Unidad Reumatologica Las Americas S.C.P., Mérida, Mexico; Instituto De Ginecologia Y Reproduccion, Lima, Peru; Organización Médica de Investigación, Buenos Aires, Argentina; Pontificial Catholic University School of Medicine, Porto Alegre, Brazil; Physician Research Collaboration, Lincoln, Nebraska, USA; University of Queensland, Brisbane, Queensland, Australia; Centro De Especialidades Médicas/Universidad Marista, Mérida, Mexico; Box Arthritis and Rheumatology of the Carolinas, Charlotte, North Carolina; Low Country Rheumatology, Charleston, South Carolina, USA; Institute of Rheumatology, Moscow, Russia; Service et Pôle de Rhumatologie, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium; Bristol-Myers Squibb, Princeton, New Jersey, USA; and Schlosspark-Klinik, Teaching Hospital of the Charité University Medicine Berlin, Berlin, Germany. · Pubmed 24584926
  • From Stanford University, Palo Alto, California, USA; Pôle de Recherche en Rhumatologie, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain and Cliniques Universitaires Saint-Luc, Brussels, Belgium; Novartis Pharma AG, Basel, Switzerland; NZOZ Centrum Medyczne Artur Racewicz, Bialystok, Poland; Medical Plus, Uherske Hradiste, Czech Republic; Arthritis Clinic, Jackson, Tennessee, USA; Konkuk University Medical Center, Seoul, South Korea; Health Research of Oklahoma, Oklahoma City, Oklahoma, USA; Centre for Inflammatory Joint Diseases, Munich, Germany; Kobe-Konan Yamate Clinic, Kobe, Japan; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA. · Pubmed 24429175
  • From the University of Alberta, Edmonton, Alberta; Augurex Life Sciences Corp., North Vancouver, British Columbia; Mount Sinai Hospital, Toronto, Ontario, Canada; Quest Diagnostics Nichols Institute, San Juan Capistrano; Stanford University Medical Center, Palo Alto, California; Hospital for Special Surgery, New York, New York; Brigham and Women's Hospital, Boston, Massachusetts, USA; Vrije Universiteit University Medical Center; Academic Medical Center/University of Amsterdam; Jan van Breemen Research Institute, Reade organization, Amsterdam; the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; University of Cambridge, Cambridge; GlaxoSmithKline, Stevenage, UK.W.P. Maksymowych, MD, Professor of Medicine, University of Alberta; S.J. Naides, MD, Quest Diagnostics Nichols Institute; V. Bykerk, MD, Hospital for Special Surgery; K.A. Siminovitch, MD, Mount Sinai Hospital; D. van Schaardenburg, MD, Jan van Breemen Research Institute; M. Boers, MD, Vrije Universiteit University Medical Center; R. Landewé, MD, Academic Medical Center/University of Amsterdam; D. van der Heijde, MD, Department of Rheumatology, Leiden University Medical Center; P-P. Tak, MD, Academic Medical Center/University of Amsterdam, University of Cambridge, GlaxoSmithKline; M.C. Genovese, MD, Stanford University Medical Center; M.E. Weinblatt, MD, Brigham and Women's Hospital; E.C. Keystone, MD, Mount Sinai Hospital; O.S. Zhukov, MS; R.W. Abolhosn, BS; J.M. Popov, MD, PhD, Quest Diagnostics Nichols Institute; K. Britsemmer, MD, Jan van Breemen Research Institute; A.W. van Kuijk, MD, Academic Medical Center/University of Amsterdam; A. Marotta, PhD, Augurex Life Sciences Corp. · From the University of Alberta, Edmonton, Alberta; Augurex Life Sciences Corp., North Vancouver, British Columbia; Mount Sinai Hospital, Toronto, Ontario, Canada; Quest Diagnostics Nichols Institute, San Juan Capistrano; Stanford University Medical Center, Palo Alto, California; Hospital for Special Surgery, New York, New York; Brigham and Women's Hospital, Boston, Massachusetts, USA; Vrije Universiteit University Medical Center; Academic Medical Center/University of Amsterdam; Jan van Breemen Research Institute, Reade organization, Amsterdam; the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; University of Cambridge, Cambridge; GlaxoSmithKline, Stevenage, UK.W.P. Maksymowych, MD, Professor of Medicine, University of Alberta; S.J. Naides, MD, Quest Diagnostics Nichols Institute; V. Bykerk, MD, Hospital for Special Surgery; K.A. Siminovitch, MD, Mount Sinai Hospital; D. van Schaardenburg, MD, Jan van Breemen Research Institute; M. Boers, MD, Vrije Universiteit University Medical Center; R. Landewé, MD, Academic Medical Center/University of Amsterdam; D. van der Heijde, MD, Department of Rheumatology, Leiden University Medical Center; P-P. Tak, MD, Academic Medical Center/University of Amsterdam, University of Cambridge, GlaxoSmithKline; M.C. Genovese, MD, Stanford University Medical Center; M.E. Weinblatt, MD, Brigham and Women's Hospital; E.C. Keystone, MD, Mount Sinai Hospital; O.S. Zhukov, MS; R.W. Abolhosn, BS; J.M. Popov, MD, PhD, Quest Diagnostics Nichols Institute; K. Britsemmer, MD, Jan van Breemen Research Institute; A.W. van Kuijk, MD, Academic Medical Center/University of Amsterdam; A. Marotta, PhD, Augurex Life Sciences Corp. · Pubmed 25128504
2013
  • Division of Immunology and Rheumatology, Stanford University, 1000 Welch Rd #203, Palo Alto, CA 94304, USA. · Pubmed 23297340
2009
  • Department of Medicine, Division of Immunology & Rheumatology, Stanford University, Stanford, CA 94305, USA. · Pubmed 19460157
2007
  • Division of Immunology and Rheumatology, Stanford University, Palo Alto, California 94304, USA. · Pubmed 17977486
Eli Lilly Corporation
2016
  • From the Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, California; Eli Lilly and Company, Indianapolis, Indiana; Bristol-Myers Squibb, Princeton, New Jersey, USA.M.C. Genovese, MD, James W. Raitt Professor of Medicine, Co-Chief of Division of Immunology and Rheumatology, Stanford University School of Medicine; D.K. Braun, MD, Medical Fellow; Eli Lilly and Company; J.S. Erickson, PhD, Statistician, Eli Lilly and Company; P.Y. Berclaz, MD, Senior Medical Director, Eli Lilly and Company; M.P. Heffernan, MD, Senior Medical Director, Eli Lilly and Company; H. Carlier, MD, Senior Medical Advisor, Eli Lilly and Company, Indianapolis; S. Banerjee, MD, Bristol-Myers Squibb. · From the Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, California; Eli Lilly and Company, Indianapolis, Indiana; Bristol-Myers Squibb, Princeton, New Jersey, USA.M.C. Genovese, MD, James W. Raitt Professor of Medicine, Co-Chief of Division of Immunology and Rheumatology, Stanford University School of Medicine; D.K. Braun, MD, Medical Fellow; Eli Lilly and Company; J.S. Erickson, PhD, Statistician, Eli Lilly and Company; P.Y. Berclaz, MD, Senior Medical Director, Eli Lilly and Company; M.P. Heffernan, MD, Senior Medical Director, Eli Lilly and Company; H. Carlier, MD, Senior Medical Advisor, Eli Lilly and Company, Indianapolis; S. Banerjee, MD, Bristol-Myers Squibb. · Pubmed 26669919
2016
  • From the Stanford University Medical Center, Palo Alto, CA (M.C.G.); Albany Medical College, Albany, NY ( J.K.); Rheumazentrum Favoriten (O.Z.) and the Medical University of Vienna ( J.S.S.) - both in Vienna; East Penn Rheumatology, Bethlehem, PA (C.L.); Rheumatology Clinic, MAK-MED, Nadarzyn, Poland (M.K.); and Eli Lilly, Indianapolis (L.X., S.D.B., A.E.K., T.E.C., T.P.R., W.L.M., S.B., D.E.S.). · Pubmed 27028914
2015
  • From the *Stanford University Medical Center, Palo Alto, CA; †NYU School of Medicine, New York, NY; ‡Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom; §Private Practice, Memphis, TN; and ∥Eli Lilly and Company, Indianapolis, IN. · Pubmed 26203826
University of California San Diego
2015
  • From the Division of Rheumatology, Stanford University, Palo Alto; Immunology, and Biostatistics, Janssen Research and Development LLC, La Jolla, California; Immunology, Janssen Research and Development, LLC, Spring House; Medical Affairs, Janssen Scientific Affairs LLC, Horsham, Pennsylvania; Quantitative Sciences, Janssen Research and Development LLC, Titusville, New Jersey, USA.M.C. Genovese, MD, Division of Rheumatology, Stanford University; E. Hsia, MD; S.M. Belkowski, PhD, Immunology, Janssen Research and Development LLC; C. Chien, PhD, Quantitative Sciences, Janssen Research and Development LLC; T. Masterson, MS; R.L. Thurmond, PhD; C.L. Manthey, PhD, Immunology, Janssen Research and Development LLC; X. Yan, PhD, Quantitative Sciences, Janssen Research and Development LLC; T. Ge, PhD, Biostatistics, Janssen Research and Development LLC; C. Franks, BS, Immunology, Janssen Research and Development LLC; A. Greenspan, MD, Medical Affairs, Janssen Scientific Affairs LLC. · From the Division of Rheumatology, Stanford University, Palo Alto; Immunology, and Biostatistics, Janssen Research and Development LLC, La Jolla, California; Immunology, Janssen Research and Development, LLC, Spring House; Medical Affairs, Janssen Scientific Affairs LLC, Horsham, Pennsylvania; Quantitative Sciences, Janssen Research and Development LLC, Titusville, New Jersey, USA.M.C. Genovese, MD, Division of Rheumatology, Stanford University; E. Hsia, MD; S.M. Belkowski, PhD, Immunology, Janssen Research and Development LLC; C. Chien, PhD, Quantitative Sciences, Janssen Research and Development LLC; T. Masterson, MS; R.L. Thurmond, PhD; C.L. Manthey, PhD, Immunology, Janssen Research and Development LLC; X. Yan, PhD, Quantitative Sciences, Janssen Research and Development LLC; T. Ge, PhD, Biostatistics, Janssen Research and Development LLC; C. Franks, BS, Immunology, Janssen Research and Development LLC; A. Greenspan, MD, Medical Affairs, Janssen Scientific Affairs LLC. · Pubmed 26233509
2014
  • From Stanford University, Palo Alto, California, USA; Leiden University Medical Center, Leiden, The Netherlands; University of Toronto, Toronto, Ontario, Canada; Centro Medico Privado de Reumatologia, San Miguel de Tucuman, Argentina; Centre Hospitalier Régional, Orleans, France; University of California, San Diego, La Jolla, California; Austin Rheumatology Research PA, Austin, Texas; (formerly) AstraZeneca, Wilmington, Delaware, USA; AstraZeneca, Macclesfield, UK; Arthritis Associates, Orlando, Florida; Brigham and Women's Hospital, Boston, Massachusetts, USA.M.C. Genovese, MD, Stanford University; D.M. van der Heijde, MD, PhD, Leiden University Medical Center; E.C. Keystone, MD, University of Toronto; A.J. Spindler, MD, Centro Medico Privado de Reumatologia; C. Benhamou, MD, Centre Hospitalier Régional; A. Kavanaugh, MD, University of California, San Diego; E. Fudman, MD, Austin Rheumatology Research PA; K. Lampl, MD; C. O'Brien, MD, PhD, (formerly) AstraZeneca; E.L. Duffield, MSc, AstraZeneca, UK; J. Poiley, MD, Arthritis Associates; M.E. Weinblatt, MD, Brigham and Women's Hospital. · From Stanford University, Palo Alto, California, USA; Leiden University Medical Center, Leiden, The Netherlands; University of Toronto, Toronto, Ontario, Canada; Centro Medico Privado de Reumatologia, San Miguel de Tucuman, Argentina; Centre Hospitalier Régional, Orleans, France; University of California, San Diego, La Jolla, California; Austin Rheumatology Research PA, Austin, Texas; (formerly) AstraZeneca, Wilmington, Delaware, USA; AstraZeneca, Macclesfield, UK; Arthritis Associates, Orlando, Florida; Brigham and Women's Hospital, Boston, Massachusetts, USA.M.C. Genovese, MD, Stanford University; D.M. van der Heijde, MD, PhD, Leiden University Medical Center; E.C. Keystone, MD, University of Toronto; A.J. Spindler, MD, Centro Medico Privado de Reumatologia; C. Benhamou, MD, Centre Hospitalier Régional; A. Kavanaugh, MD, University of California, San Diego; E. Fudman, MD, Austin Rheumatology Research PA; K. Lampl, MD; C. O'Brien, MD, PhD, (formerly) AstraZeneca; E.L. Duffield, MSc, AstraZeneca, UK; J. Poiley, MD, Arthritis Associates; M.E. Weinblatt, MD, Brigham and Women's Hospital. · Pubmed 25225285
2009
34 Other Locations Show
Yearly article counts 091391012586831
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.